The BIOFIRE® FILMARRAY® Pneumonia Plus (PNplus) Panel is a cutting-edge molecular test that quickly identifies the pathogens causing pneumonia. It detects a wide range of bacteria, viruses, and fungi from a single respiratory sample, providing comprehensive results in just a few hours. This advanced panel also screens for important antibiotic resistance genes, helping to tailor effective treatment plans.
Traditional pneumonia testing methods can be slow and may miss mixed infections. The PNplus Panel uses multiplex PCR technology to deliver fast, accurate, and comprehensive detection of multiple pathogens and resistance markers simultaneously. This allows doctors to start the right treatment sooner, improving patient outcomes and reducing hospital stays.
By providing rapid and detailed information about the infection and its antibiotic resistance, the PNplus Panel guides doctors in choosing targeted therapies. This minimizes the use of broad-spectrum antibiotics, lowers the risk of complications, and supports faster recovery—especially important for critically ill or immunocompromised patients.
Note: Home Sample Collection is only for Pathology lab tests.
Results are typically available within 6 to 12 hours, much faster than traditional culture methods
It detects a broad range of bacteria, viruses, fungi, and antibiotic resistance genes commonly responsible for pneumonia.
It is recommended for hospitalized patients with suspected pneumonia, especially those in the ICU or with weakened immune systems.
By quickly identifying the exact cause and resistance patterns, the test helps doctors prescribe targeted treatments, improving recovery and reducing unnecessary antibiotic use.
Yes, the test can be used for both adults and pediatric patients with suspected pneumonia, depending on clinical indications.
Yes, the multiplex technology allows simultaneous detection of multiple pathogens and resistance genes from a single sample.
The BIOFIRE® FILMARRAY® PNplus Panel complements traditional culture methods by providing faster results; cultures may still be done for confirmation or antibiotic sensitivity testing.